GGrantIndex
← Leaderboards

Minnetronix, Inc.

St. Paul, MN

Compare ↔
$14,804,783
Total funding
12
Grants

Funding over time

peak $3.4M · FY201121
$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$14,804,783 · 12

By mechanism

R44$7,437,171 · 4
R42$6,344,095 · 3
R41$674,863 · 3
R43$348,654 · 2

Investigators at Minnetronix, Inc.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

Development of a Miniature Hydrodynamically Suspended Intrathoracic Tesla Pump$1,693,830
R44 · FY2012 · HL
Development of an Infant VAD System for Long Term Uni- and Bi-ventricular Support$1,501,784
R44 · FY2012 · HL
Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter$1,499,976
R44 · FY2020 · NS
Validation of Novel Therapeutic Approach for Cryptococcal Meningitis$1,000,000
R42 · FY2017 · AI
Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis$998,500
R42 · FY2018 · AI
Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis$970,147
R42 · FY2019 · AI
Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis$939,151
R42 · FY2020 · AI
Transcutaneous Energy Transmission System for Fully Implantable VADs$748,797
R44 · FY2014 · HL
Transcutaneous Energy Transmission System for Fully Implantable VADs$721,018
R44 · FY2015 · HL
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases$665,919
R42 · FY2018 · CA
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases$646,349
R42 · FY2019 · CA
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases$637,111
R42 · FY2020 · CA
Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter$561,439
R44 · FY2019 · NS
Validation of Novel Therapeutic Approach for Cryptococcal Meningitis$486,918
R42 · FY2018 · AI
Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter$395,323
R44 · FY2021 · NS
Directed Antifungal Therapy for HIV-associated Cryptococcal Meningitis$224,976
R41 · FY2015 · AI
Directed Chemotherapy Delivery for Leptomeningeal Metastases$224,970
R41 · FY2016 · CA
Development of a Novel Therapeutic Approach for Cryptococcal Meningitis$224,917
R41 · FY2015 · AI
Development of an Infant VAD System for Long Term Uni- and Bi-ventricular Support$217,048
R44 · FY2011 · HL
Transcutaneous Energy Transmission System for Fully Implantable VADs$198,682
R43 · FY2012 · HL